Research ArticleArticle
A Novel Semisynthetic Inhibitor of the FRB Domain of Mammalian Target of Rapamycin Blocks Proliferation and Triggers Apoptosis in Chemoresistant Prostate Cancer Cells
Samy A.F. Morad, Maximilian Schmid, Berthold Buchele, Hans-Ullrich Siehl, Menna El Gafaary, Oleg Lunov, Tatiana Syrovets and Thomas Simmet
Molecular Pharmacology December 3, 2012, mol.112.081349; DOI: https://doi.org/10.1124/mol.112.081349
Samy A.F. Morad
Ulm University
Maximilian Schmid
Ulm University
Berthold Buchele
Ulm University
Hans-Ullrich Siehl
Ulm University
Menna El Gafaary
Ulm University
Oleg Lunov
Ulm University
Tatiana Syrovets
Ulm University
Thomas Simmet
Ulm University
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
A Novel Semisynthetic Inhibitor of the FRB Domain of Mammalian Target of Rapamycin Blocks Proliferation and Triggers Apoptosis in Chemoresistant Prostate Cancer Cells
Samy A.F. Morad, Maximilian Schmid, Berthold Buchele, Hans-Ullrich Siehl, Menna El Gafaary, Oleg Lunov, Tatiana Syrovets and Thomas Simmet
Molecular Pharmacology December 3, 2012, mol.112.081349; DOI: https://doi.org/10.1124/mol.112.081349
Research ArticleArticle
A Novel Semisynthetic Inhibitor of the FRB Domain of Mammalian Target of Rapamycin Blocks Proliferation and Triggers Apoptosis in Chemoresistant Prostate Cancer Cells
Samy A.F. Morad, Maximilian Schmid, Berthold Buchele, Hans-Ullrich Siehl, Menna El Gafaary, Oleg Lunov, Tatiana Syrovets and Thomas Simmet
Molecular Pharmacology December 3, 2012, mol.112.081349; DOI: https://doi.org/10.1124/mol.112.081349
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement